The University of Edinburgh
Evaluation of patients with acute coronary syndromes using cardiac magnetic resonance imaging and bioelectrical and biochemical markers
Abstract
dc:description.abstractINTRODUCTION: Cardiac disease is a major cause of morbidity and mortality worldwide and therapeutic advances continue to be made. Improved accuracy of diagnosis and risk stratification is therefore important. Advanced imaging using contrast enhanced magnetic imaging ( ceMRI) is under investigation for assessment of myocardial necrosis in both acute and chronic settings due to ischaemic and non -ischaemic aetiologies. Consecutive patients with an incident episode of chest pain necessitating hospital admission were recruited and underwent ceMRI. CeMRI was considered the gold standard for determining presence of ischaemic myocardial necrosis and used to evaluate current ECG guidelines in acute chest pain syndromes. ST segment elevation on the presenting ECG determines the acute reperfusion strategy but will not detect all infarcts and additional consideration of ST depression termed, "STEMI equivalent" may reduce the burden of missed AMI. Infarct size (IS) was measured by manual planimetry of regions of delayed hyperenhancement (DE) and then correlated with routinely available biochemical and bioelectrical markers. The evolution of infarct size and characteristics were then followed using at ceMRI at 4 time points out to 1 year. The role of inflammation in MI using CRP as the marker was also investigated. Finally, additional clinical information was provided by performing ceMRI in this group of patients and the findings are presented.
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 2012
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Martin, Thomas N.
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- http://hdl.handle.net/1842/30451